| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.06 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.25 | 0.06 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |